Capital Investment Advisory Services’s Eli Lilly LLY Stock Holding History

Capital Investment Advisory Services’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.4M	Buy	8,697 +166	+2%	+$170K	0.64%	31
2026 Q1	$7.85M	Sell	8,531 -163	-2%	-$165K	0.57%	40
2025 Q4	$9.34M	Sell	8,694 -101	-1%	-$96.6K	0.66%	34
2025 Q3	$6.71M	Buy	8,795 +40	+0.5%	+$29.8K	0.53%	42
2025 Q2	$6.83M	Buy	8,755 +671	+8%	+$521K	0.56%	41
2025 Q1	$6.68M	Buy	8,084 +377	+5%	+$314K	0.6%	36
2024 Q4	$5.95M	Sell	7,707 -126	-2%	-$104K	0.57%	38
2024 Q3	$6.94M	Buy	7,833 +2,585	+49%	+$2.32M	0.66%	34
2024 Q2	$4.75M	Buy	5,248 +422	+9%	+$338K	0.49%	43
2024 Q1	$3.75M	Buy	4,826 +179	+4%	+$127K	0.4%	55
2023 Q4	$2.71M	Sell	4,647 -66	-1%	-$38.5K	0.25%	68
2023 Q3	$2.53M	Buy	4,713 +436	+10%	+$225K	0.25%	70
2023 Q2	$2.01M	Sell	4,277 -2,105	-33%	-$883K	0.2%	87
2023 Q1	$2.19M	Sell	6,382 -1,147	-15%	-$387K	0.26%	79
2022 Q4	$2.75M	Buy	7,529 +332	+5%	+$118K	0.33%	63
2022 Q3	$2.33M	Sell	7,197 -279	-4%	-$88.4K	0.3%	65
2022 Q2	$2.42M	Sell	7,476 -513	-6%	-$154K	0.29%	70
2022 Q1	$2.29M	Buy	7,989 +1,039	+15%	+$267K	0.25%	83
2021 Q4	$1.92M	Buy	6,950 +1,109	+19%	+$281K	0.23%	95
2021 Q3	$1.35M	Buy	5,841 +771	+15%	+$190K	0.17%	120
2021 Q2	$1.16M	Buy	5,070 +599	+13%	+$120K	0.15%	135
2021 Q1	$835K	Sell	4,471 -89	-2%	-$17.4K	0.12%	170
2020 Q4	$770K	Buy	4,560 +304	+7%	+$45.4K	0.11%	183
2020 Q3	$630K	Sell	4,256 -374	-8%	-$57.9K	0.12%	167
2020 Q2	$760K	Sell	4,630 -80	-2%	-$12.3K	0.15%	130
2020 Q1	$653K	Buy	4,710 +1,920	+69%	+$264K	0.16%	126
2019 Q4	$367K	Sell	2,790 -41	-1%	-$4.75K	0.1%	203
2019 Q3	$317K	Hold	2,831	–	–	0.09%	210
2019 Q2	$304K	Buy	2,831 +92	+3%	+$10.8K	0.09%	217
2019 Q1	$355K	Buy	2,739 +56	+2%	+$6.81K	0.13%	148
2018 Q4	$310K	Buy	2,683 +125	+5%	+$14K	0.13%	145
2018 Q3	$274K	Buy	+2,558	New	+$256K	0.13%	174

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Capital Investment Advisory Services's LLY Position: Q2 2026 in Review

Capital Investment Advisory Services increased its Eli Lilly (LLY) stake by 1.9% in Q2 2026, buying an estimated $170K and bringing the position to 8,697 shares worth $10.4M. The position accounts for 0.64% of the portfolio, ranked #31.

Capital Investment Advisory Services first reported a position in LLY in Q3 2018 and has held it in 32 quarters since. 1,615 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Capital Investment Advisory Services held 8,697 shares of Eli Lilly worth $10.4M as of Q2 2026.
Capital Investment Advisory Services bought 166 Eli Lilly shares in Q2 2026, an estimated $170K.
Eli Lilly made up 0.64% of Capital Investment Advisory Services's portfolio in Q2 2026, its #31 holding.
Capital Investment Advisory Services first reported a position in Eli Lilly in Q3 2018 and has held it in 32 quarters since.
1,615 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Capital Investment Advisory Services's 13F filing for Q2 2026, filed 23 Jul 2026.